Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
Condition: Polycystic Ovary Syndrome Interventions: Drug: Metformin Hydrochloride 500 MG; Drug: Cabergoline 0.5 MG; Drug: Metformin Hydrochloride 500 MG + Cabergoline 0.5 MG Sponsor: Al-Rasheed University College Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Fortamet | Hormones | Iraq Health | Metformin | Ovaries | Polycystic Ovary Syndrome | Research